90318173 - CYTOCOM

Information

  • Trademark
  • 90318173
  • Serial Number
    90318173
  • Filing Date
    November 13, 2020
    5 years ago
  • Transaction Date
    February 13, 2023
    2 years ago
  • Status Date
    February 13, 2023
    2 years ago
  • Location Date
    February 13, 2023
    2 years ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SHINER, MARK W
  • Attorney Docket Number
    SBI3-TM010
    Attorney Name
    John J. O'Malley
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
4000
Mark Identification
CYTOCOM
Case File Statements
  • GS0411: Educational services, namely, conducting classes, seminars, conferences, and workshops in the medical, pharmaceutical, and healthcare fields and distributing printed course materials in conjunction therewith; providing online journals, namely, blogs in the medical, pharmaceutical and health fields
  • GS0051: Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immunocompromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements
  • GS0421: Medical and pharmaceutical research services; pharmaceutical research and development
Case File Event Statements
  • 2/13/2023 - 2 years ago
    27 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/13/2023 - 2 years ago
    26 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/13/2023 - 2 years ago
    25 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 7/27/2022 - 3 years ago
    24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/27/2022 - 3 years ago
    23 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/27/2022 - 3 years ago
    22 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/29/2022 - 3 years ago
    21 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 6/10/2022 - 3 years ago
    20 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 11/19/2021 - 4 years ago
    19 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/19/2021 - 4 years ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/19/2021 - 4 years ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/19/2021 - 4 years ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/19/2021 - 4 years ago
    15 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/12/2021 - 4 years ago
    14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/12/2021 - 4 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/12/2021 - 4 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/12/2021 - 4 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/12/2021 - 4 years ago
    10 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 5/12/2021 - 4 years ago
    9 - WITHDRAWN FROM PUB OTQR REQUEST Type: PBTQ
  • 5/7/2021 - 4 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/26/2021 - 4 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/26/2021 - 4 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/26/2021 - 4 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/26/2021 - 4 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/23/2021 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/13/2021 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/17/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP